Literature DB >> 19877012

Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells.

Arnob Banerjee1, Felix Schambach, Caitlin S DeJong, Scott M Hammond, Steven L Reiner.   

Abstract

Micro-RNA (miR) are increasingly recognized as critical regulators of tissue-specific patterns of gene expression. CD4+ T cells lacking miR-155, for example, exhibit bias towards Th2 differentiation, indicating that the absence of individual miR could alter CD4+ T-cell differentiation. We now show that miR-155 is induced upon T-cell activation and that it promotes Th1 differentiation when over-expressed in activated CD4+ T cells. Antagonism of miR-155 leads to induction of IFN-gamma receptor alpha-chain (IFN-gammaRalpha), and a functional miR-155 target site is identified within the 3' untranslated region of IFN-gammaRalpha. These results identify IFN-gammaRalpha as a second miR-155 target in T cells and suggest that miR-155 contributes to Th1 differentiation in CD4+ T cells by inhibiting IFN-gamma signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19877012      PMCID: PMC2807623          DOI: 10.1002/eji.200939381

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  29 in total

1.  High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma.

Authors:  Anke van den Berg; Bart-Jan Kroesen; Klaas Kooistra; Debora de Jong; Jane Briggs; Tjasso Blokzijl; Susan Jacobs; Joost Kluiver; Arjan Diepstra; Ewerton Maggio; Sibrand Poppema
Journal:  Genes Chromosomes Cancer       Date:  2003-05       Impact factor: 5.006

2.  T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC.

Authors:  Deanna Haasch; Yung-Wu Chen; Regina M Reilly; X Grace Chiou; Sandra Koterski; Morey L Smith; Paul Kroeger; Kerri McWeeny; Donald N Halbert; Karl W Mollison; Stevan W Djuric; James M Trevillyan
Journal:  Cell Immunol       Date:  2002 May-Jun       Impact factor: 4.868

3.  Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells.

Authors:  Susan Kohlhaas; Oliver A Garden; Cheryl Scudamore; Martin Turner; Klaus Okkenhaug; Elena Vigorito
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

4.  T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells.

Authors:  A A Lighvani; D M Frucht; D Jankovic; H Yamane; J Aliberti; B D Hissong; B V Nguyen; M Gadina; A Sher; W E Paul; J J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

5.  Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.

Authors:  T F Gajewski; F W Fitch
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

6.  T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells.

Authors:  Maryam Afkarian; John R Sedy; Jianfei Yang; Nils G Jacobson; Nezih Cereb; Soo Y Yang; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2002-05-13       Impact factor: 25.606

7.  Cell cycle controlling the silencing and functioning of mammalian activators.

Authors:  A C Mullen; A S Hutchins; A V Villarino; H W Lee; F A High; N Cereb; S Y Yang; X Hua; S L Reiner
Journal:  Curr Biol       Date:  2001-10-30       Impact factor: 10.834

8.  Ligand-independent down-regulation of IFN-gamma receptor 1 following TCR engagement.

Authors:  H Skrenta; Y Yang; S Pestka; C G Fathman
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

9.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

10.  Control of effector CD8+ T cell function by the transcription factor Eomesodermin.

Authors:  Erika L Pearce; Alan C Mullen; Gislâine A Martins; Connie M Krawczyk; Anne S Hutchins; Valerie P Zediak; Monica Banica; Catherine B DiCioccio; Darrick A Gross; Chai-An Mao; Hao Shen; Nezih Cereb; Soo Y Yang; Tullia Lindsten; Janet Rossant; Christopher A Hunter; Steven L Reiner
Journal:  Science       Date:  2003-11-07       Impact factor: 47.728

View more
  115 in total

1.  Regulation of acute graft-versus-host disease by microRNA-155.

Authors:  Parvathi Ranganathan; Catherine E A Heaphy; Stefan Costinean; Nicole Stauffer; Caroline Na; Mehdi Hamadani; Ramasamy Santhanam; Charlene Mao; Patricia A Taylor; Sukhinder Sandhu; Gang He; Arwa Shana'ah; Gerard J Nuovo; Alessandro Lagana; Luciano Cascione; Susanna Obad; Oliver Broom; Sakari Kauppinen; John C Byrd; Michael Caligiuri; Danilo Perrotti; Gregg A Hadley; Guido Marcucci; Steven M Devine; Bruce R Blazar; Carlo M Croce; Ramiro Garzon
Journal:  Blood       Date:  2012-03-09       Impact factor: 22.113

2.  Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8.

Authors:  Sharmistha Bhattacharyya; Nagaraja S Balakathiresan; Clifton Dalgard; Usha Gutti; David Armistead; Cathy Jozwik; Meera Srivastava; Harvey B Pollard; Roopa Biswas
Journal:  J Biol Chem       Date:  2011-01-31       Impact factor: 5.157

Review 3.  MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development.

Authors:  Katie Podshivalova; Daniel R Salomon
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

Review 4.  Role of miR-155 in the regulation of lymphocyte immune function and disease.

Authors:  Nabila Seddiki; Vedran Brezar; Nicolas Ruffin; Yves Lévy; Sanjay Swaminathan
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

5.  Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response.

Authors:  Lianhua Yan; Fen Hu; Xiaofei Yan; Yuzhen Wei; Wenhan Ma; Ya Wang; Shuai Lu; Zhaohui Wang
Journal:  J Mol Med (Berl)       Date:  2016-04-06       Impact factor: 4.599

6.  Dynamic BRG1 recruitment during T helper differentiation and activation reveals distal regulatory elements.

Authors:  Supriyo De; Andrea L Wurster; Patricia Precht; William H Wood; Kevin G Becker; Michael J Pazin
Journal:  Mol Cell Biol       Date:  2011-01-24       Impact factor: 4.272

7.  MicroRNA-155 Reinforces HIV Latency.

Authors:  Debbie S Ruelas; Jonathan K Chan; Eugene Oh; Amy J Heidersbach; Andrew M Hebbeler; Leonard Chavez; Eric Verdin; Michael Rape; Warner C Greene
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

Review 8.  Modulation of immune responses following solid organ transplantation by microRNA.

Authors:  Nayan J Sarma; Venkataswarup Tiriveedhi; Sabarinathan Ramachandran; Jeffrey Crippin; William Chapman; T Mohanakumar
Journal:  Exp Mol Pathol       Date:  2012-10-01       Impact factor: 3.362

Review 9.  Non-coding RNAs: the new central dogma of cancer biology.

Authors:  Phei Er Saw; Xiaoding Xu; Jianing Chen; Er-Wei Song
Journal:  Sci China Life Sci       Date:  2020-09-11       Impact factor: 6.038

10.  Silencing of miR155 promotes the production of inflammatory mediators in Guillain-Barré syndrome in vitro.

Authors:  Yu-Zhong Wang; Xun-Gang Feng; Qi-Guang Shi; Yan-Lei Hao; Yan Yang; Ai-Mei Zhang; Qing-Xia Kong
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.